MetLife Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.02M Buy
32,228
+1,895
+6% +$59.7K 0.01% 1307
2025
Q1
$993K Sell
30,333
-489
-2% -$16K 0.01% 1370
2024
Q4
$1.11M Buy
30,822
+1,394
+5% +$50.4K 0.01% 1356
2024
Q3
$918K Hold
29,428
0.01% 1436
2024
Q2
$787K Buy
29,428
+3,423
+13% +$91.6K ﹤0.01% 1477
2024
Q1
$887K Hold
26,005
0.01% 1366
2023
Q4
$753K Hold
26,005
0.01% 1453
2023
Q3
$717K Hold
26,005
0.01% 1416
2023
Q2
$782K Hold
26,005
0.01% 1407
2023
Q1
$942K Hold
26,005
0.01% 1247
2022
Q4
$928K Sell
26,005
-834
-3% -$29.7K 0.01% 1258
2022
Q3
$909K Sell
26,839
-1,030
-4% -$34.9K 0.01% 1241
2022
Q2
$806K Hold
27,869
0.01% 1333
2022
Q1
$901K Buy
27,869
+9,872
+55% +$319K 0.01% 1400
2021
Q4
$525K Hold
17,997
﹤0.01% 1481
2021
Q3
$480K Hold
17,997
﹤0.01% 1543
2021
Q2
$554K Sell
17,997
-4,497
-20% -$138K ﹤0.01% 1507
2021
Q1
$589K Hold
22,494
0.01% 1429
2020
Q4
$566K Hold
22,494
0.01% 1427
2020
Q3
$469K Hold
22,494
0.01% 1397
2020
Q2
$534K Hold
22,494
0.01% 1340
2020
Q1
$405K Hold
22,494
0.01% 1324
2019
Q4
$534K Hold
22,494
0.01% 1431
2019
Q3
$618K Hold
22,494
0.01% 1307
2019
Q2
$744K Hold
22,494
0.01% 1257
2019
Q1
$788K Hold
22,494
0.01% 1190
2018
Q4
$747K Hold
22,494
0.01% 1139
2018
Q3
$1.13M Hold
22,494
0.01% 1072
2018
Q2
$1.35M Buy
22,494
+1,022
+5% +$61.2K 0.02% 916
2018
Q1
$983K Hold
21,472
0.01% 1016
2017
Q4
$856K Buy
+21,472
New +$856K 0.01% 1096